Fig. 2.

Western blots (WB) performed on frontal cortex of mice treated with haloperidol decanoate (N = 11) or vehicle (N = 9) for 2 weeks. (A) No differences were observed in total GSK-3β. (B) Inactivated pGSK-3β was reduced in haloperidol treated mice. (C) The ratio of inactive/total pGSK-3β/total GSK-3β was reduced in haloperidol treated mice, suggesting an activation of the kinase. The insert displays typical gel lanes from immunoblots used for quantitative analyses with ImageJ.